oasis 1 oral semaglutide 50 mg obesity lancet 2023 The Science oasis 1 trial oral semaglutide

Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8

Ignite Fundings commitment to transparency and accountability sets it apart

But it does play a role in muscle regulation, sensitizing it to exercise stimuli and testosterones actions

Licorice Extract: Soothes inflammation and helps in lightening dark spots

Reducing Appetite : GLP-1 acts on the brain to promote feelings of fullness and satiety, helping to reduce overall food intake

When glutathione neutralizes a free radical, it becomes "spent." Vitamin C can help jump-start it back into its active form